Compare LOAN & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LOAN | YI |
|---|---|---|
| Founded | 1989 | 2010 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Retail-Drug Stores and Proprietary Stores |
| Sector | Real Estate | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.9M | 49.0M |
| IPO Year | 1999 | 2018 |
| Metric | LOAN | YI |
|---|---|---|
| Price | $4.29 | $7.07 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 20.8K | 19.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 10.33% | N/A |
| EPS Growth | ★ 2.08 | N/A |
| EPS | ★ 0.35 | N/A |
| Revenue | ★ $9,688,641.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.47 | N/A |
| P/E Ratio | $12.17 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.25 | $2.48 |
| 52 Week High | $6.05 | $11.35 |
| Indicator | LOAN | YI |
|---|---|---|
| Relative Strength Index (RSI) | 25.71 | 47.05 |
| Support Level | N/A | $6.75 |
| Resistance Level | $4.59 | $7.44 |
| Average True Range (ATR) | 0.07 | 0.22 |
| MACD | -0.01 | -0.26 |
| Stochastic Oscillator | 0.00 | 8.46 |
Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.